Price Chart

Executive Summary

The Ninth Circuit Court of Appeals ruled that key provisions of California's AB 290—specifically the Reimbursement Cap, Patient Disclosure Requirement, and Financial Assistance Restriction—are unconstitutional under the First Amendment, and that the remaining constitutional provision (Coverage Disclosure Requirement) cannot be severed. This is a significant legal win for Fresenius Medical Care and other dialysis providers, as it removes major regulatory burdens on charitable contributions and patient communications.

Court Ruling Details

Key Facts

• Ninth Circuit invalidated three core provisions of AB 290: the Reimbursement Cap, Patient Disclosure Requirement, and Financial Assistance Restriction, citing violations of First Amendment rights to association.
• The court ruled that the unconstitutional provisions cannot be severed from the remaining Coverage Disclosure Requirement, effectively striking down AB 290 in its entirety as applied to the plaintiffs.
• The ruling affirms that dialysis providers like Fresenius can continue making charitable contributions to organizations like the American Kidney Fund (AKF) without facing reimbursement penalties.
• The Safe Harbor Provision was deemed moot because the July 1, 2020 deadline passed without action.

Financial Impact

Removes potential financial and operational restrictions on Fresenius' ability to benefit from private insurance reimbursements via patient premium assistance programs.

Risk Factors

• California may appeal to the U.S. Supreme Court or introduce revised legislation to achieve similar goals through narrower means.
• Future regulatory actions at the federal level could still target provider-charity relationships.

Market Snapshot

Investment Themes

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

US Market Status